A low dose of calcipotriol, which is already approved for the treatment of psoriasis, may improve healing and prevent wound infections in patients with recessive dystrophic epidermolysis bullosa (RDEB), a study showed.
Read MoreStudies of high-risk patients with peripheral artery disease or critical limb ischemia and those with complicated disease states are some of the late-breaking clinical trials that have been selected for presentation at VIVA.18 from Nov. 5 to 8 in Las Vegas.
Read MoreWearing pressure-sensing smart insoles (SurroSense Rx, Orpyx Medical Technologies) reduced diabetic foot ulcer recurrence by up to 86% in compliant patients in a randomized single-blinded trial in high-risk individuals with type 1 and 2 diabetes.
Read MoreChronic skin lesions are an important medical health problem. Chronic skin lesions are associated with high costs for the National Health Service and reduce quality of life for the patient. The availability of means to reduce the healing time of skin ulcers is a medical and public health priority.
Read MoreIn the last half-century, the development of biodegradable polymeric materials for biomedical applications has advanced significantly. Biodegradable polymeric materials are favored in the development of therapeutic devices, including temporary implants and three-dimensional scaffolds for tissue engineering.
Read MorePatients with peripheral artery disease who received a drug-eluting stent with a polymer coating and a lower drug dose density had better patency compared with a DES without a polymer coating and a higher drug dose density, according to 12-month results from the IMPERIAL trial presented at TCT 2018 and published in The Lancet.
Read MoreTrainer Suresh Kumar, who was once involved in first-aid work, used to think that wound caring meant washing the wound, cleaning it with antiseptic and applying a plaster. He later realised wound management is much more than that because lives and limbs can be saved when medical staff are well trained in this skill.
Read MoreAVITA Medical, a global regenerative medicine company, today announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat severe thermal burns in patients 18 years and older.
Read MoreThe Food and Drug Administration (FDA) has approved the Eluvia Drug-Eluting Vascular Stent System (Boston Scientific) for the treatment of peripheral artery disease. The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.
Read MoreOne of the most common orthopedic problems is the incidence of pressure ulcer followed by immobility. This study aimed to investigate the effect of Aloe Vera gel on the prevention of pressure ulcer in patients hospitalized in the orthopedic ward.
Read More